Smoking cessation programs and other preventive strategies for chronic obstructive pulmonary disease

Journal of Association of Physicians of India

Volumn 60, Issue SUPPL FEB2012, 2012, Pages 53-56

  Kumar, Raj ^a   Vijayan, V K ^a  

^a UNIVERSITY OF DELHI   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATTITUDE TO HEALTH; CHRONIC OBSTRUCTIVE LUNG DISEASE; COUNSELING; DRUG THERAPY; HEALTH EDUCATION; HUMAN; METHODOLOGY; PASSIVE SMOKING; SMOKING; SMOKING CESSATION; TOBACCO DEPENDENCE; TREATMENT OUTCOME;

COUNSELING; DRUG THERAPY; HEALTH EDUCATION; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; SMOKING CESSATION; TOBACCO SMOKE POLLUTION; TOBACCO USE DISORDER; TREATMENT OUTCOME;

EID: 84871913708     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. National Heart, Lung, and Blood Institute. Morbidity & Mortality: Chartbook on Cardiovascular, Lung, and Blood Diseases. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, Bethesda, MD. 1998. Available from: URL: www.nhlbi.nih.gov/nhlbi/seiin//other/cht-book/htm. (accessed on 30/7/2011)
2. Murray CJL, Lopez AD. Evidence-based health policy-lessons from the Global Burden of Disease Study. Science 1996;274:740-743.
3. D Behera. NCCP Textbook of Respiratory Medicine. 1st Ed. In: Kumar R, editor. Smoking and Lung Diseases. Jaypee Brothers Medical Publishers, New Delhi; 747-51.
4. World Health Organization. International Classification of Disease and Related Health Problems; 10th (Edn). Geneva: World Health Organisation; 1994.
5. Vijayan VK, Kumar R. Tobacco cessation in India. Indian J Chest Dis Allied Sci 2005;47:5-8.
6. Global Initiative for Chronic Obstructive Lung disease. Global Strategy for the diagnosis,management and prevention of Chronic Obstructive Pulmonary Disease. Updated 2010. Available at http://www.goldcopd.org.(accessed on 30/7/2011)
7. National Institute for Clinical Excellence (NICE). Chronic obstructive pulmonary disease:national clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 2004;59(Suppl. 1):1-232.
8. Fiore MC, Bailey WC, Cohen SJ, et al. Treating tobacco use and dependence: quick referenceguide for clinicians. US Department of A health and Human Services. Rockville, Public HealthService, 2000.
9. West R, McNeill A, Ras M. Smoking cessation guidelines for health professionals: an update. Thorax 2000;55:987-999.
10. World Health Organization (WHO). European partnership to reduce tobacco dependence: WHOevidence based recommendations on the treatment of tobacco dependence. Geneva, WHO, 2001.
11. National Institute for Clinical Excellence (NICE). Guidance on the use of nicotine replacementtherapy (NRT) and Bupropion for smoking cessation. National Institute for Clinical ExcellenceTechnology Appraisal Guidance No. 39, April 2002. www.nice.org.uk.(accessed on 30/7/2011)
12. Andersson JE, Joremby DE, Scott WJ, Fiore MC. Treating tobacco use and dependence. Chest 2002;121:932-941.
13. Anthonisen NR, Connet JE, Kiley JP, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung health study. JAMA 1994;272:1497-505.
14. Anthonisen NR, Skeans MA, Wise RA, et al. The effects of smoking cessation intervention on 14.5 year mortality: a randomized clinical trial. Ann Intern Med 2005;142:233-9.
15. Smoking cessation interventions and continuous abstinence rate at one year. Kumar R, Kushwah AS, Gopal C, et al. Indian J Chest Dis Allied Sci 2007;49:201-207.
16. Baillie AJ, Mattick RP, Hall W, et al. Meta-analytic review of the efficacy of smoking cessation interventions. Drug and Alcohol Review 1994;13:157-70.
17. Wilson DH, Wakefield MA, Steven ID, et al. "Sick of Smoking": evaluation of a targeted minimal smoking cessation intervention in general practice. Med J Aust 1990;152:518-21.
18. The tobacco use and dependence clinical practice guideline panel, staff, and consortium representatives. A clinical practice guideline for treating tobacco use and dependence. JAMA 2000;28:3244-54.
19. American Medical Association. Guidelines for the diagnosis and treatment of nicotine dependence: how to help patients stop smoking. Washington DC: American Medical Association 1994.
20. Glynn TJ, Manley MW. How to help your patients stop smoking. A National Cancer Institute manual for physicians. Bethesda, MD: Department of Health and Human Services, Public Health Service, National Institute of Health, National Cancer Institute; 1990.
21. Glynn TJ, Manley MW, Pechacek TF. Physician-initiated smoking cessation program: the National Cancer Institute trials. Prog Clin Biol Res 1990;339:11-25.
22. Lancaster T, Stead L, Silagy C, Sowden A. Effectiveness of interventions to help people stop smoking: findings from the Cochrane Library. BMJ 2000;321:355-8.
23. Tonnesen P, Mikkelson K, Bremann L. Nurse-conducted smoking cessation in patients with COPD using nicotine sublingual tablets and behavioural support. Chest 2006;130:334-42.
24. Schwartz JL. Review and evaluation of smoking cessation methods: United Staes and Canada, 1978-1085. Bethesda, MD: National institute of Health; 1987.
25. Fiore MC, Bailey WC, Cohen SJ. Smoking cessation: information for specialists. Rockville, MD: US Department of Health and Human Service, Agency for Health Care policy and Research and Centers for Disease Control and Prevention; 1996.
26. Singh P, Kumar R. Assessment of the effectiveness of sustained release Bupropion and intensive physician advice in smoking cessation. Lung India 2010;27:11-18.
27. Jorenby DE, Hays JT, Rigotti NA, et al. Efficacy of varenicline, an alpha4beta2nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release Bupropion for smoking cessation: a randomized control trial. JAMA 2006;296:56-63.
28. Nides M, Oncken C, Gonzales D, et al. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist: results from a 7-week, randomized, placebo- and Bupropion-controlled trial with 1-year follow-up. Arch Intern Med 2006;166:1561-8.
29. Tonstad S, Tonnesen P, Hajek P, et al. Effects of maintenance therapy with varenicline on smoking cessation: a randomized control trial. JAMA 2006;296:64-71.
30. Kumar R, Prakash S, Kushwah AS, et al. Smoking cessation-control measures. Lung India 2005;22:68-73.
31. Clinical Practice Guideline. Treating Tobacco use and Dependence. US Department of Health & Human services. Public Health Service. June 2000.